Pharma Innovation Programme Singapore (PIPS)
The Pharma Innovation Programme Singapore (PIPS) is an industry-led platform that aims to synergistically and strategically bring together public sector research capabilities and domain expertise of the pharmaceutical industry to enhance the productivity and operational efficiency within Singapore’s pharmaceutical sector through leveraging novel manufacturing technologies and data analytics.
From Digital Twins to Real Time AI-supported Plant Operation
From Digital Twins to Real Time AI-supported Plant Operation is led by Prof Alexei Lapkin, Prof Markus Kraft, and Dr Lianlian Jiang. This is a 2-year project that commenced in July 2023 and aims to demonstrate a methodology of management and development of physical models-based digital twins for pharmaceutical process development, operation, and management. The project’s initial phase involves a literature review of process ontologies aligning with project requirements, with a focus on the OntoCAPE ontology, which is used to represent concepts in the domain of Computer Aided Process Engineering.
Automated evaluation of environmental impacts of pharma manufacturing processes
Automated evaluation of environmental impacts of pharma manufacturing processes is led by Prof Alexei Lapkin. This is a 3-year project that commenced in July 2023 and aims to create best-in-class solutions for rapid evaluation of environmental impacts in the complex setting of the production of medicines. CARES has sub-contracted the research and development work on this project to its spin-off company Chemical Data Intelligence (CDI) Pte Ltd. CDI works with proprietary data, is set up to productise software for application in the chemical industry, and hence is ideally positioned to deliver this project. This work will combine data-driven modelling, first principles models, and hybrid models to create a predictive tool for life cycle impacts.
Completed PIPS projects are listed together with our other completed projects on this page.